Main > ONCOLOGY (**) > Leukemia>Lymphoblastic>Acute>R/R*** > TREAT.: > CH. N. TisagenlecleuCel>

---

CH. N. TisagenlecleuCel>'s subsections
(*) USA Approval Date: 2017. 08.30
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 17
Patent>UpDate: 2017. 08.29
Suspension for IV Infusion
TradeMark
TradeMark Web-Site

CH. N. TisagenlecleuCel>'s products
This section has no products